MVIS US Listed Pharmaceutical 25 Index
The MVIS US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.
Country and Sector Weightings
MVIS Sector Indices are pure-play sector indices. Companies must generate at least 50% of their revenues in the target sector to be eligible for index inclusion. Country and Sector weightings are based on the weightings of all index components in a certain country or sector.
| Country | Components | Weight |
| Canada | 1 | 1.22% |
| United States | 13 | 56.17% |
| Denmark | 1 | 4.85% |
| France | 1 | 5.00% |
| Ireland | 2 | 4.47% |
| Netherlands | 1 | 4.97% |
| Switzerland | 1 | 5.29% |
| United Kingdom | 3 | 10.10% |
| Israel | 1 | 3.46% |
| Japan | 1 | 4.46% |
| Total | 25 | 100.00% |
| Sector | Components | Weight |
| Health Care | 25 | 100.00% |
| Total | 25 | 100.00% |
Size Weightings
- Large-Cap: companies with a market capitalisation above 6,000 mln
USD
- Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln
USD
- Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln
USD
- Micro-Cap: companies with a market capitalisation up to 200 mln
USD
| Size | Market Cap | Components | Weight |
| Large-Cap | 2,797,287,421,000 USD | 21 | 96.34% |
| Mid-Cap | 11,665,274,900 USD | 3 | 3.43% |
| Small-Cap | 571,302,460 USD | 1 | 0.23% |
| Micro-Cap | - | - | - |
| Total | 2,809,523,998,360 USD | 25 | 100.00% |
